Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours Β· Estimated delivery Sep 23 - Sep 28
Rarely, allergic reactions or adverse effects related to the injection technique may occur
Unlike full-length growth hormone, AOD-9604 does not stimulate IGF-1 production or interact with traditional growth hormone receptors, indicating an independent mechanism of action that has been the subject of ongoing investigation
Tirzepatide controls blood sugar by stimulating insulin release, lowering glucagon levels and regulating appetite and energy metabolism for weight management
Long-lasting effects One injection lasts 4-6 weeks, so patients only need injections every month or two for maintenance
Researchers should note that AOD 9604s pharmaceutical development was discontinued due to insufficient efficacy findings in clinical trials, which is relevant context when evaluating either compounds utility in a research setting.
Acta Biomater (2015) 26:295305
US$ 25.04
US$ 24.49
US$ 24.49
US$ 23.04
US$ 28.05